HCA Healthcare, Inc. $HCA Stake Lessened by Prospera Financial Services Inc

Prospera Financial Services Inc trimmed its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 19.5% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 13,345 shares of the company’s stock after selling 3,240 shares during the period. Prospera Financial Services Inc’s holdings in HCA Healthcare were worth $5,688,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors also recently made changes to their positions in the company. Norges Bank purchased a new position in HCA Healthcare during the second quarter valued at approximately $1,152,408,000. Pacer Advisors Inc. grew its holdings in shares of HCA Healthcare by 6,115.3% during the 3rd quarter. Pacer Advisors Inc. now owns 911,096 shares of the company’s stock valued at $388,309,000 after acquiring an additional 896,437 shares in the last quarter. Viking Global Investors LP raised its holdings in shares of HCA Healthcare by 58.5% during the second quarter. Viking Global Investors LP now owns 1,872,133 shares of the company’s stock worth $717,214,000 after acquiring an additional 690,773 shares in the last quarter. VIRGINIA RETIREMENT SYSTEMS ET Al purchased a new position in HCA Healthcare in the second quarter valued at about $109,337,000. Finally, HRT Financial LP purchased a new stake in shares of HCA Healthcare during the 2nd quarter worth about $81,596,000. Institutional investors and hedge funds own 62.73% of the company’s stock.

Insider Buying and Selling at HCA Healthcare

In other news, EVP Michael S. Cuffe sold 1,500 shares of the business’s stock in a transaction that occurred on Tuesday, February 3rd. The stock was sold at an average price of $498.09, for a total transaction of $747,135.00. Following the sale, the executive vice president directly owned 30,003 shares in the company, valued at approximately $14,944,194.27. The trade was a 4.76% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Insiders own 1.30% of the company’s stock.

HCA Healthcare Stock Up 0.8%

Shares of HCA stock opened at $501.48 on Wednesday. The stock has a 50 day moving average of $479.90 and a 200-day moving average of $445.63. The firm has a market cap of $114.43 billion, a PE ratio of 17.67, a price-to-earnings-growth ratio of 1.52 and a beta of 1.36. HCA Healthcare, Inc. has a 12 month low of $295.00 and a 12 month high of $527.55.

HCA Healthcare (NYSE:HCA) last released its earnings results on Tuesday, January 27th. The company reported $8.01 EPS for the quarter, beating the consensus estimate of $7.37 by $0.64. HCA Healthcare had a net margin of 8.97% and a negative return on equity of 409.11%. The firm had revenue of $19.51 billion during the quarter, compared to analysts’ expectations of $19.67 billion. During the same period in the prior year, the company earned $6.22 EPS. The business’s quarterly revenue was up 6.7% compared to the same quarter last year. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. As a group, equities analysts predict that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, March 31st. Shareholders of record on Tuesday, March 17th will be issued a $0.78 dividend. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.72. The ex-dividend date of this dividend is Tuesday, March 17th. This represents a $3.12 annualized dividend and a yield of 0.6%. HCA Healthcare’s payout ratio is currently 10.99%.

Analyst Upgrades and Downgrades

A number of analysts have issued reports on the stock. Weiss Ratings reiterated a “buy (b)” rating on shares of HCA Healthcare in a research note on Monday, December 29th. The Goldman Sachs Group upped their price objective on shares of HCA Healthcare from $520.00 to $558.00 and gave the stock a “buy” rating in a report on Wednesday, January 28th. Oppenheimer boosted their price target on HCA Healthcare from $500.00 to $540.00 and gave the stock an “outperform” rating in a research report on Wednesday, January 28th. Mizuho set a $540.00 price objective on HCA Healthcare in a research note on Monday, February 2nd. Finally, TD Cowen reissued a “buy” rating on shares of HCA Healthcare in a research report on Wednesday, January 28th. Sixteen equities research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, HCA Healthcare currently has an average rating of “Moderate Buy” and a consensus target price of $523.27.

HCA Healthcare Company Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.